1.79
price up icon0.00%   0.00
after-market Dopo l'orario di chiusura: 1.81 0.02 +1.12%
loading

Perché le azioni Vigil Neuroscience Inc (VIGL) sono in ribasso?

Abbiamo notato un calo di 9.09% nelle azioni di Vigil Neuroscience Inc (VIGL) durante la sessione di negoziazione di 2025-04-08. Sebbene ciò possa essere attribuito alla normale volatilità o a vari fattori interni ed esterni, tieni presente che stiamo monitorando attivamente la situazione e forniremo aggiornamenti tempestivi il prima possibile!
2023-11-17:

Vigil Neuroscience Stock (VIGL) dropped by 40.03% from $6.67 to $4.00 in the trading on Friday November 17, 2023. The reason why VIGL stock down today is due to the interim data from its Phase 2 IGNITE proof-of-concept clinical trial in patients with ALSP. The data, representing the first six patients following six months of treatment with 20 mg/kg of iluzanebart, supports the drug's safety and tolerability, and showed target engagement and downstream pharmacological activity, consistent with Phase 1 data. Directionally supportive changes were observed on MRI and NfL biomarkers of disease progression in individual patients, and the company expects to report full Phase 2 IGNITE results in Q3 2024.

$20.59
price up icon 0.24%
$69.69
price up icon 1.06%
$32.20
price up icon 0.53%
$23.46
price down icon 36.06%
$102.02
price down icon 15.36%
biotechnology ONC
$244.90
price down icon 4.40%
Capitalizzazione:     |  Volume (24 ore):